Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece
Anticancer Research · 2025
DOI: 10.21873/anticanres.17624 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Anticancer Research, 2025. Verfasst von Evangelos Bournakis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Iaso General Clinic, Athens, Greece. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Pyrimidines, Sulfonamides, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Iaso General Clinic, Athens, Greece.
- St. Luke's Hospital, Thessaloniki, Greece.
- Evaggelismos General Hospital of Athens, Athens, Greece.
- Theagenio Cancer Hospital of Thessaloniki, Thessaloniki, Greece.
- 424 General Military Hospital, Thessaloniki, Greece.
- Mitera Hospital, Athens, Greece.
Zitieren
APA
Bournakis, E., Xanthakis, I., Vaslamatzis, M., Makrantonakis, P., Karanikiotis, C., Athanasiadis, I., Ardavanis, A., Papakotoulas, P., Samantas, E., Papandreou, C., Michailidou, M., Katsaounis, P., & Christodoulou, C. (2025). Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece. Anticancer Research. https://doi.org/10.21873/anticanres.17624
Vancouver
Bournakis E, Xanthakis I, Vaslamatzis M, Makrantonakis P, Karanikiotis C, Athanasiadis I, et al. Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece. Anticancer Research. 2025. doi:10.21873/anticanres.17624
BibTeX
@article{Bournakis2025,
author = {Bournakis, Evangelos and Xanthakis, Ioannis and Vaslamatzis, Michail and Makrantonakis, Parisis and Karanikiotis, Charisios and Athanasiadis, Ilias and Ardavanis, Alexandros and Papakotoulas, Pavlos and Samantas, Epaminondas and Papandreou, Christos and Michailidou, Maria and Katsaounis, Panagiotis and Christodoulou, Christos},
title = {Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17624}
}
EUVIMED